Serum interleukin-5 levels correlate with disease activity of Churg–Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid

Author： Taki H   Shinoda K   Hounoki H   Ogawa R   Ishizawa S   Sugiyama E   Tobe K  

Publisher： Informa Healthcare

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.39, Iss.4, 2010-08, pp. : 341-343

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Churg-Strauss Vasculitis in a Patient Treated with Omalizumab

By Bargagli Elana   Madioni Chiara   Olivieri Carmela   Penza Francesco   Rottoli Paola  

Journal of Asthma, Vol. 45, Iss. 2, 2008-03 ,pp. : 115-116

Informa Healthcare

Access to resources Recommend Favorite

A Case of Churg-Strauss Syndrome Treated with Montelukast

By  

Medical Principles and Practice, Vol. 21, Iss. 2, 2011-10 ,pp. : 186-189

Karger

Access to resources Recommend Favorite

Churg-Strauss syndrome

By Guillevin L.   Pagnoux C.   Cohen P.  

Revue Francaise dAllergologie et dImmunologie Clinique, Vol. 44, Iss. 1, 2004-01 ,pp. : 96-102

Elsevier

Access to resources Recommend Favorite

Osler and the Churg-Strauss Syndrome

By  

European Neurology, Vol. 57, Iss. 3, 2007-01 ,pp. : 185-187

Karger

Access to resources Recommend Favorite

Severe Churg-Strauss syndrome with mediastinal lymphadenopathy treated with interferon therapy

By Lesens O.   Hansmann Y.   Nerson J.   Pasquali J.-L.   Gasser B.   Wihlm J.-M.   Christmann D.  

European Journal of Internal Medicine, Vol. 13, Iss. 7, 2002-10 ,pp. : 458-462

Elsevier

Access to resources Recommend Favorite